Temperature monitoring of congestive heart failure patients as an indicator of worsening condition

Patent 6821249 Issued on November 23, 2004. Estimated Expiration Date:

September 19, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

Patient monitoring and data processing system
Patent #: 4216462
Issued on: 08/05/1980
Inventor: McGrath , et al.

Pressure monitoring interconnect system
Patent #: 4508103
Issued on: 04/02/1985
Inventor: Calisi

Temperature driven rate responsive cardiac pacemaker
Patent #: 4688573
Issued on: 08/25/1987
Inventor: Alt

Exercise-responsive cardiac pacemaker lead
Patent #: 4726383
Issued on: 02/23/1988
Inventor: Cook , et al.

Automatically self-alarming electronic clinical thermometer
Patent #: 4763112
Issued on: 08/09/1988
Inventor: Hsieh

Temperature-controlled cardiac pacemaker responsive to body motion
Patent #: 4905697
Issued on: 03/06/1990
Inventor: Heggs, et al.

Implantable device with circadian rhythm adjustment
Patent #: 4922930
Issued on: 05/08/1990
Inventor: Adkins, et al.

Vital signs monitoring and communication system
Patent #: 4981139
Issued on: 01/01/1991
Inventor: Pfohl

Temperature-based, rate-modulated cardiac therapy apparatus and method
Patent #: 5005574
Issued on: 04/09/1991
Inventor: Fearnot, et al.

Device for computer-assisted monitoring of the body
Patent #: 5050612
Issued on: 09/24/1991
Inventor: Matsumura

More ...

Inventors

Assignee

Board of Regents, The University of Texas System

Application

No. 10247667 filed on 09/19/2002

US Classes:

600/300, DIAGNOSTIC TESTING600/549, Temperature detection128/898Methods

Examiners

Primary: Jones, Mary Beth
Assistant: Astorino, Michael

Attorney, Agent or Firm

Burgess, P.C.; Tim L.

International Class

A61B 500

Abstract

Indication of worsening health condition in patients with congestive heart failure using the analysis of the speed and pattern of temperature change in a way that is individualized toward patient's health condition.

Other References

Adams KF, Dunlap SH, Suteta CA, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol. 1996; 28: 1781-1788.
Anastasiou-Nana MI, Nanas JN, Karagounis LA, et al. Relation of dispersion of QRS and QT in patients with advanced congestive heart failure to cardiac and sudden death mortality. Am J Cardiol. 2000; 85:1212-1217.
Anguita M, Arizon JM, Bueno G, et al. Clinical and hemodynamic predictors of survival in patients aged <65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol. 1993; 72: 413-417.
Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997; 349: 1050-1053.
Astrup P, Engel K, Severinghaus JW, et al. The influence of temperature and pH on the dissociation curve of oxyhemoglobin of human blood. Scand J Clin Lab Invest. 1965; 17: 515-523.
Bart BA, Shaw LK, McCants CB, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol. 1997; 30: 1002-1008.
Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA. 1993; 13: 1702-1707.
Blum A, Miller H. Pathophysiological role of cytokines in congestive heart failure. Annu Rev Med. 2001; 52: 15-27.
Brengelmann GL. Body temperature regulation in heart failure. Cardiologia. 1996; 41: 1033-1043.
Chomsky DB, Lang CC, Rayos GH, et al. Hemodynamic exercise testing: a valuable tool in the selection of cardiac transplantation candidates. Circulation. 1996; 94: 3176-3183.
Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984; 311: 819-823.
Cohn JN, Rector TS. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol. 1988; 62: 25A-30A.
Cohn JN. Prognostic factors in heart failure: poverty amidst a wealth of variables. J Am Coll Cardiol. 1989; 14: 571-572.
Dargie HJ, Cleland JG, Leckie BJ, et al. Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation. 1987; 75: IV98-IV107.
De Groote P, Millaire A, Foucher-Hossein C, et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol. 1998; 32: 948-954.
Deng MC, De Meester JM, Smits JM, Heinecke J, Scheld HH. Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. BMJ. 2000; 321: 540-545.
Dries DL, Exner DV, Gersh BJ, et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol. 1998; 32: 695-703.
Francis GS, Cohn JN, Johnson G, et al. Plasma norepinephrine, plasma renin activity, and congestive heart failure: Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation. 1993; 87 (Suppl 6): V140-V148.
Gentilello LM, Jurkovich GJ, Stark MS, Hassantash SA, O'Keefe GE. Is hypothermia in the victim of major trauma protective or harmful! A randomized, prospective study. Ann Surg Oct. 1997; 226(4):439-47; discussion 447-9.
Givertz MM, Colucci WS. New targets for heart failure therapy: endothelin, inflammatory cytokines and oxidative stress. Lancet. 1998; 352(Suppl 1): S134-S138.
Gradman A, Deedwania P, Cody R, et al. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol. 1989; 14:564-570.
Gradman AH, Deedwania PC. Predictors of mortality in patients with heart failure. Cardiol. Clin. 1994; 12: 25-35.
Hallstrom A, Pratt CM, Greene HL, et al. Relations between heart failure, ejection fraction, arrhythmia suppression, and mortality: analysis of the Cardiac Arrhythmia Suppression Trial. J Am Coll Cardiol. 1995; 25: 1250-1257.
Hulsmann M, Stanek B, Frey B, et al. Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure. J Am Coll Cardiol. 1998; 32: 1695-1700.
Jurkovich GJ, Greiser WB, Luterman A, Curreri PW. Hypothermia in trauma victims: an ominous predictor of survival. J Trauma Sep. 1987;27(9):1019-24.
Kihara T, Biro S, Imamura M, et al. Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure. J Am Coll Cardiol. 2002; 39: 754-759.
Klingenheben T, Zabel M, D'Agostino RB, et al. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet. 2000; 356: 651-652.
Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation. 1999; 99: 1435-1440.
Lassvik CT, Areskog N. Angina in cold environment. Reactions to exercise. Br Heart J. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling—concepts and clinical Implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol. 2000; 35: 569-582, 1979; 42: 396-401.
Myers J, Gullestad L, Vagelos R, et al. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med. 1998; 15: 286-293.
Packer M. Potential role of potassium as a determinant of morbidity and mortality in patients with systemic hypertension and congestive heart failure. Am J Cardiol. 1990, 65: 45E-52E.
Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation. 1985; 72:681-685.
Parameshwar J, Keegan J, Sparrow J, et al. Predictors of prognosis in severe chronic heart failure. Am Heart J. 1992; 123: 421-426.
Poehlman ET, Scheffers J, Gottlieb SS, et al. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med. 1994; 121: 860-862.
Rector TS, Cohn JN. Prognosis in congestive heart failure. Annu Rev Med. 1994; 45: 341-350.
Rodriguez-Garcia JL, Paule A, Dominguez J, et al. Effects of the angiotensin II antagonist losartan on endothelin-1 and norepinephrine plasma levels during cold pressor test in patients with chronic heart failure. Int J Cardiol. 1999; 70: 293-301.
Shellock FG, Swan HJ, Rubin SA. Muscle and femoral vein temperatures during short-term maximal exercise in heart failure. J Appl Physiol. 1985; 58: 400-408.
Shibutani K, Komatsu T, Kubal K, Sanchala V, Kumar V, Bizzarri DV. Critical level of oxygen delivery in anesthetized man. Crit Care Med Aug. 1983;11 (8):640-3.
Siddiqui H, Patel S, Lal BN, et al. Hypothermia: a new indicator of imminent death in congestive heart failure. J Am Coll Cardiol. 1999; 33: 212A.
Szlachic J, Massie BM, Kramer BL, et al. Correlates and prognostic implications of exercise capacity in chronic congestive heart failure. Am J Cardiol. 1986; 55: 1037-1042.
Tei C, Horikiri Y, Park JC, et al. Acute hemodynamic improvement by thermal vasodilation in congestive heart failure. Circulation. 1995; 91: 2582-2590.
Tsuji H, Larson MG, Venditti FJ, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framington Heart Study. Circulation. 1996; 94: 2850-2855.
Tsutamoto T, Hisanaga T, Wada A, et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 1998; 31: 391-398.
Weg JG. Oxygen transport in adult respiratory distress syndrome and other acute circulatory problems: relationship of oxygen delivery and oxygen consumption. Crit Care Med May 1991;19(5):650-7.
Westheim A, Os I, Thaulow E, et al. Haemodynamic and neurohumoral effects of cold pressor test in severe heart failure. Clin Physiol. 1992, 12: 95-106.
Whittle JL, Bates JH. Thermoregulatory failure secondary to acute illness: complications and treatment. Arch Intern Med. 1979, 139: 418-421.